Perifosine CAS: 157716-52-4
MF: C25H52NO4P
MW: 461.66
An alkylphospholipid which inhibits Akt activation and the anti-apoptotic MAPK pathway.

Perifosine (CAS 157716-52-4)

Perifosine | CAS 157716-52-4 is rated 5.0 out of 5 by 2.
  • y_2020, m_8, d_13, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_364571, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 123ms
  • REVIEWS, PRODUCT
5
2
4
0
3
0
2
0
1
0
Alternate Names: KRX-0401
Application: Perifosine is an alkylphospholipid which inhibits Akt activation and the anti-apoptotic MAPK pathway
CAS Number: 157716-52-4
Purity: ≥98%
Molecular Weight: 461.66
Molecular Formula: C25H52NO4P
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Perifosine (also KRX-0401) is an alkylphospholipid (octadecyl-(1,1-dimethyl-4-piperidylio) phosphate) which inhibits Akt activation. Perifosine has been studied for potential treatment of a wide variety of cancers. Targeting cellular membranes, Perifosine modulates membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth. Perifosine also inhibits the anti-apoptotic mitogen-activated protein kinase (MAPK) pathway and modulates the balance between the MAPK and pro-apoptotic stress-activated protein kinase (SAPK/JNK) pathways, thereby inducing apoptosis. Perifosine has a lower gastrointestinal toxicity profile than the related agent Miltefosine (sc-203135).

Appearance :
Powder
Physical State :
Solid
Storage :
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
148177
SMILES :
CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

HOW CAN I DETERMINE THE DOSE OF PERIFOSINE THAT I WILL ADMINISTER IN MICE MODEL/ CELL LINE TO INDUCE AKT-INHIBITION?

Asked by: BUKHARI
Thank you for your question. We have not tested Perifosine: sc-364571 in animals, so we do not have this information. Our compounds are not pharmaceutical grade and not manufactured under GMP guidelines. Please consult your principal investigator and your animal care and use committee (ACUC) regarding the use of our compounds in animals. We would also recommend you consult the primary literature to determine any previously reported dosing information for inducing Akt inhibition.
Answered by: Technical Support
Date published: 2017-04-17
  • y_2020, m_8, d_13, h_15CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_364571, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 140ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Product features are excellent Jiang X et al. (PubMed ID30040162 ) found that ANXA8 inhibited Perifosine(the AKT inhibitor) .Combine other results proved ANXA8 activated the phosphorylation of the target protein kinase B (Akt) protein.
Date published: 2019-08-08
Rated 5 out of 5 by from Holohan et al Holohan et al. (PubMed ID 26307677) found that the AKT inhibitor, Perifosine, inhibited telomerase activity and induced telomere shortening in various cell lines in vitro -SCBT Publication Review
Date published: 2015-06-23
  • y_2020, m_8, d_13, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_364571, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 19ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.